Loading provider…
Loading provider…
Neuro-ophthalmology Physician in Philadelphia, PA
NPI: 1285634105Primary Practice Location
WILLS EYE HOSPITAL
840 Walnut St, Philadelphia, PA
Primary Employer
Wills Eye Ophthalmology Clinic, Inc
willseye.org
HQ Phone
Get MD Robert's Phone NumberMobile
Get MD Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 181 | 183 |
| 2 | 93880Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | 157 | 160 |
| 3 | 92083Measurement of field of vision during daylight conditions | 151 | 163 |
| 4 | 92133Diagnostic imaging of optic nerve of eye | 151 | 164 |
| 5 | 92012Eye and medical examination for diagnosis and treatment, established patient | 130 | 172 |
Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy.
Authors: Jose-Alain Sahel, Nancy Newman, Rustum Karanjia, Mark Moster
Publication Date: 2019-10-05
Authors: Sergott, Robert C, Carelli, Valerio, Newman, Nancy J, Biousse, Valérie, Yu-Wai-Man, Patrick, Vignal-Clermont, Catherine, Josse, Constant, Taiel, Magali, Sahel, José-Alain, Barboni, Piero
Journal: Invest Ophthalmol Vis Sci
OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool.
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine Tablets
Lead Sponsor: Neuro-Ophthalmologic Associates, PC
Collaborators: Mallinckrodt
Intervention / Treatment: DRUG: ACTHAR